Westfield Capital Management
SGMO

Westfield Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Westfield Capital Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-34,000
Closed -$367K – 333
2014
Q3 		$367K Hold
34,000
– – ﹤0.01% 287
2014
Q2 		$519K Buy
+34,000
New +$489K ﹤0.01% 291
2013
Q4 		– Sell
-46,300
Closed -$486K – 352
2013
Q3 		$486K Buy
46,300
+24,700
+114% +$245K ﹤0.01% 307
2013
Q2 		$169K Buy
+21,600
New +$188K ﹤0.01% 355

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Westfield Capital Management's SGMO Position: Q4 2014 in Review

Westfield Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2014, closing a stake of 34,000 shares — an estimated $367K sold.

Westfield Capital Management first reported a position in SGMO in Q2 2013 and held it in 4 quarters. The position peaked at $519K in Q2 2014. 158 funds tracked by Wall St. Rank hold SGMO as of Q4 2014.

  • Westfield Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • Westfield Capital Management sold 34,000 SANGAMO THERAPEUTICS INC shares in Q4 2014, an estimated $367K.
  • Westfield Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 4 quarters.
  • Westfield Capital Management's SANGAMO THERAPEUTICS INC position peaked at $519K in Q2 2014.
  • 158 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2014.

Based on Westfield Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.